FR2192838B1 - - Google Patents

Info

Publication number
FR2192838B1
FR2192838B1 FR7325905A FR7325905A FR2192838B1 FR 2192838 B1 FR2192838 B1 FR 2192838B1 FR 7325905 A FR7325905 A FR 7325905A FR 7325905 A FR7325905 A FR 7325905A FR 2192838 B1 FR2192838 B1 FR 2192838B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7325905A
Other versions
FR2192838A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo NV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo NV filed Critical Akzo NV
Publication of FR2192838A1 publication Critical patent/FR2192838A1/fr
Application granted granted Critical
Publication of FR2192838B1 publication Critical patent/FR2192838B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695—Corticotropin [ACTH]
    • C07K14/6955—Corticotropin [ACTH] with at least 1 amino acid in D-form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1027—Tetrapeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FR7325905A 1972-07-15 1973-07-13 Expired FR2192838B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NLAANVRAGE7209839,A NL175618C (nl) 1972-07-15 1972-07-15 Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat bevat, alsmede een werkwijze ter bereiding van dergelijke peptiden.

Publications (2)

Publication Number Publication Date
FR2192838A1 FR2192838A1 (fr) 1974-02-15
FR2192838B1 true FR2192838B1 (fr) 1977-01-28

Family

ID=19816526

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7325905A Expired FR2192838B1 (fr) 1972-07-15 1973-07-13

Country Status (13)

Country Link
US (1) US3853838A (fr)
JP (1) JPS5936611B2 (fr)
AU (1) AU471401B2 (fr)
BE (1) BE802335A (fr)
CA (1) CA1019723A (fr)
CH (1) CH605674A5 (fr)
DE (1) DE2335826C2 (fr)
FR (1) FR2192838B1 (fr)
GB (1) GB1439225A (fr)
HU (1) HU169437B (fr)
NL (1) NL175618C (fr)
SE (1) SE392721B (fr)
ZA (1) ZA734648B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7607683A (nl) * 1976-07-12 1978-01-16 Akzo Nv Werkwijze ter bereiding van nieuwe peptiden en peptide-derivaten en de toepassing hiervan.
US4144228A (en) * 1976-05-07 1979-03-13 G. D. Searle & Co. Methionine5 -enkephalin sulfoxides and sulfones
NL7607684A (nl) * 1976-07-12 1978-01-16 Akzo Nv Werkwijze ter bereiding van nieuwe peptiden en peptide-derivaten en de toepassing hiervan.
US4356119A (en) * 1978-09-28 1982-10-26 Nordisk Insulinlaboratorium Therapeutically active polypeptides or acid addition salts and a process for producing such compounds
US4623715A (en) 1984-10-22 1986-11-18 Hoechst Aktiengeselleschaft Novel peptides which are active on the central nervous system and have an action on the cholinergic system
WO1986003746A1 (fr) * 1984-12-14 1986-07-03 La Trobe University Inhibiteur aux amino-acides et aux peptides de l'elastase leucocytique humaine
US7592304B2 (en) 1999-10-01 2009-09-22 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US7632803B2 (en) * 1999-10-01 2009-12-15 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
WO2011133348A1 (fr) * 2010-04-21 2011-10-27 Pharmacofore, Inc. Compositions comprenant des promédicaments de type amphétamine clivables par enzyme et leurs inhibiteurs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL278010A (fr) * 1961-05-04 1900-01-01
NL6509727A (fr) * 1965-07-28 1967-01-30
GB1230472A (fr) * 1967-07-10 1971-05-05

Also Published As

Publication number Publication date
SE392721B (sv) 1977-04-18
NL175618C (nl) 1984-12-03
AU5798373A (en) 1975-01-16
AU471401B2 (en) 1976-04-29
DE2335826A1 (de) 1974-01-31
BE802335A (fr) 1974-01-14
DE2335826C2 (de) 1984-01-05
NL7209839A (fr) 1974-01-17
NL175618B (nl) 1984-07-02
JPS5936611B2 (ja) 1984-09-05
ZA734648B (en) 1974-06-26
FR2192838A1 (fr) 1974-02-15
JPS4951278A (fr) 1974-05-18
CH605674A5 (fr) 1978-10-13
GB1439225A (en) 1976-06-16
CA1019723A (en) 1977-10-25
US3853838A (en) 1974-12-10
HU169437B (fr) 1976-11-28

Similar Documents

Publication Publication Date Title
JPS4958085A (fr)
JPS5222157B2 (fr)
JPS4880951A (fr)
FR2171447A1 (fr)
FR2192838B1 (fr)
FR2175526B1 (fr)
JPS4894336A (fr)
FR2191648A5 (fr)
JPS4920227A (fr)
JPS4933287A (fr)
FR2195260A5 (fr)
FR2172977A1 (fr)
JPS4942034A (fr)
FR2178595A5 (fr)
JPS5237419B2 (fr)
JPS4992963A (fr)
JPS497398U (fr)
FI51131B (fr)
JPS4884249A (fr)
JPS4953298U (fr)
JPS4982037U (fr)
CH570821A5 (fr)
CH577500A5 (fr)
BE790496A (fr)
CH582368A5 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse